Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by inviolablspiriton Nov 29, 2024 3:57pm
107 Views
Post# 36338188

Trading Window

Trading WindowI see the insiders are taking advantage of their trading window before financials to pick up shares.  I see Perry picked up 250 000 @ 5 cents = $12 500 and then sold 44 000 @ 29 cents =  $12 760 to cover the expense.  Fraser sold 100 000 of his 250 000 @ 30 cents = $30 000 probably to both cover the $12 500 expense of buying the options and to have an enjoyable Christmas.  Who knows, perhaps he's taking the family on a vacation.  And obviously the Jodie Butts filing is clearly a misprint.  LOL  
350 000 shares @ $350 000 =$122.5 billion!!!   She's defintely the wealthiest one in this company.  It must have been pocket change.  lol   Can I cash my shares out at that price????
<< Previous
Bullboard Posts
Next >>